MedPath
HSA Product

NIVOLUMAB BMS CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML

Product approved by Health Sciences Authority (SG)

Basic Information

NIVOLUMAB BMS CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML

INFUSION, SOLUTION CONCENTRATE

Regulatory Information

SIN15117P

November 9, 2016

Prescription Only

Therapeutic

INTRAVENOUS DRIP

August 10, 2023

June 3, 2025

Company Information

BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.

Active Ingredients

Nivolumab

Strength: 10 mg/mL

© Copyright 2025. All Rights Reserved by MedPath